ViaCyte's Series C - III Round

ViaCyte raised a round of funding on August 08, 2014.

ViaCyte, a private company that has emerged as a provider in the field of regenerative medicine, is focused on developing a novel therapy for the treatment of diabetes. The Company's lead product is b…

Articles about ViaCyte's Series C - III Round: